The total return over the past 12 months is +8.85% vs. +19.98% for the S&P 500. So far it's up +32.44% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +8.85% | (4.79%) | (8.30%) | +14.33% | +25.58% | +18.55% |
| Total Return CAGR | +8.85% | (4.79%) | (8.30%) | +14.33% | +25.58% | +18.55% |
| Revenue CAGR | +15.54% | +15.83% | +18.03% | +26.09% | +33.82% | +58.54% |
| Net Income CAGR | +74.93% | +40.87% | +13.51% | N/A | N/A | N/A |
| EPS CAGR | +76.19% | +34.47% | +10.31% | N/A | N/A | N/A |
| Free Cash Flow CAGR | +146.15% | +44.45% | +69.49% | +67.47% | N/A | N/A |
| Operating Cash Flow CAGR | +77.05% | +31.36% | +33.73% | +42.95% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
DexCom, Inc. (DXCM)
| Year | Start price | End price | DXCM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $66.37 | $87.90 | +32.44% | +13.55% | +18.89% |
| 2025 | $77.77 | $66.37 | (14.66%) | +17.72% | (32.38%) |
| 2024 | $124.09 | $77.77 | (37.33%) | +24.89% | (62.22%) |
| 2023 | $113.24 | $124.09 | +9.58% | +26.19% | (16.61%) |
| 2022 | $134.24 | $113.24 | (15.64%) | (18.17%) | +2.53% |
| 2021 | $92.43 | $134.24 | +45.23% | +28.74% | +16.49% |
| 2020 | $54.69 | $92.43 | +69.01% | +18.37% | +50.64% |
| 2019 | $29.95 | $54.69 | +82.60% | +31.22% | +51.38% |
| 2018 | $14.35 | $29.95 | +108.71% | (4.56%) | +113.27% |
| 2017 | $14.93 | $14.35 | (3.88%) | +21.70% | (25.58%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
